Finance
An Analysis Of The Behavior Of UroGen Pharma Ltd (URGN) Stock
UroGen Pharma Ltd (NASDAQ:URGN) price on Thursday, March 28, rose 0.27% above its previous day’s close as an upside momentum from buyers pushed the stock’s
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.